Minimum InhibitoryConcentrations(mcg/mL) Disk Diffusion(zone diameter in mm) Pathogen S I R S I R Enterobacteralesa M100 standard is recognized Acinetobacter spp. ≤1 2 ≥4 – – […]

Safety Announcement [8-1-2013]  The U.S. Food and Drug Administration (FDA) is informing the public that acetaminophen has been associated with a risk of rare but serious skin […]

Recognized Interpretive Criteria Minimum InhibitoryConcentrations(mcg/mL) Disk Diffusion(zone diameter in mm) Pathogen S I R S I R Enterobacteralesa M100 standard is recognized Enterococcus spp. M100 standard […]

For Immediate Release: June 14, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the […]

The quarterly submission deadlines for proposals to the Rare Disease Endpoint Advancement Pilot Program are March 31, June 30, September 30, and December 31.  Sponsors may […]

[6/14/2024] Today, FDA issued a proposed administrative order, to address a safety issue related to over-the-counter (OTC) monograph drug products containing acetaminophen. Based on a comprehensive […]

6/14/2024 La Paix contains hidden drug ingredient 1/30/2024 Arize contains hidden drug ingredient 1/30/2024 Schwinnng contains hidden drug ingredient 1/30/2024 Sustain® contains hidden drug ingredients 1/2/2024 […]

[6-14-2024] The Food and Drug Administration is advising consumers not to purchase or use La Paix, a product promoted and sold for sexual enhancement on various […]

[6-14-2024] The Food and Drug Administration is advising consumers not to purchase or use Umary, a product promoted and sold for pain on various websites, including https://www.solovital.com […]